Venture Investors

Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.

SkySpecs, Inc. is a technology company based in Ann Arbor, Michigan, with an additional office in Amsterdam, Netherlands, that specializes in automating operations and maintenance for the wind energy industry through unmanned aerial vehicles. Founded in 2012, the company provides a range of services including analytics, wind turbine blade services, and engineering projects. Its offerings also encompass collaborative software solutions for managing and analyzing data from various sources, as well as digitization and planning for repair campaigns. Notably, SkySpecs has developed Horizon, a reporting software that serves as a central repository for operations and maintenance data related to wind turbine blades, facilitating task management, communication with third parties, and execution of large-scale repair projects. By leveraging its industry expertise and innovative technologies, SkySpecs aims to enhance productivity and efficiency for its clients within the renewable energy sector.

SkySpecs, Inc. is a technology company based in Ann Arbor, Michigan, with an additional office in Amsterdam, Netherlands, that specializes in automating operations and maintenance for the wind energy industry through unmanned aerial vehicles. Founded in 2012, the company provides a range of services including analytics, wind turbine blade services, and engineering projects. Its offerings also encompass collaborative software solutions for managing and analyzing data from various sources, as well as digitization and planning for repair campaigns. Notably, SkySpecs has developed Horizon, a reporting software that serves as a central repository for operations and maintenance data related to wind turbine blades, facilitating task management, communication with third parties, and execution of large-scale repair projects. By leveraging its industry expertise and innovative technologies, SkySpecs aims to enhance productivity and efficiency for its clients within the renewable energy sector.

SkySpecs, Inc. is a technology company based in Ann Arbor, Michigan, with an additional office in Amsterdam, Netherlands, that specializes in automating operations and maintenance for the wind energy industry through unmanned aerial vehicles. Founded in 2012, the company provides a range of services including analytics, wind turbine blade services, and engineering projects. Its offerings also encompass collaborative software solutions for managing and analyzing data from various sources, as well as digitization and planning for repair campaigns. Notably, SkySpecs has developed Horizon, a reporting software that serves as a central repository for operations and maintenance data related to wind turbine blades, facilitating task management, communication with third parties, and execution of large-scale repair projects. By leveraging its industry expertise and innovative technologies, SkySpecs aims to enhance productivity and efficiency for its clients within the renewable energy sector.

Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.

NeuMoDx Molecular, Inc. is a molecular diagnostics company based in Ann Arbor, Michigan, founded in 2012. It specializes in developing solutions for molecular diagnostic testing in hospital and clinical reference laboratories. The company’s platform provides in-vitro testing tools that enhance the efficiency and cost-effectiveness of laboratory operations. By improving the capabilities of laboratory professionals, NeuMoDx aims to increase the adoption of molecular diagnostic testing among medical providers, facilitating earlier and more accurate disease identification and treatment. In 2013, NeuMoDx changed its name from Molecular Systems Corporation and has since become a subsidiary of QIAGEN N.V.

UpTo, Inc. is a company that specializes in developing a social calendar application for smartphones. Founded in 2011 and based in Detroit, Michigan, UpTo provides a platform that allows users to publish and manage their organization's calendar while privately connecting with friends, family, and colleagues to share events selectively. The application offers a streamlined view of important upcoming events, eliminating clutter and focusing on what matters most. Users can easily add events, syncing seamlessly across both mobile and web platforms, and can integrate with existing calendars such as Google Calendar and Outlook. The service is designed to cater to both individuals and organizations, enhancing the way they manage and share their schedules.

Tissue Regeneration Systems Inc. is a start-up medical device company based in Plymouth, Michigan, with an additional office in Kirkland, Washington, and a research facility in Ann Arbor, Michigan. Founded in 2005, the company specializes in a skeletal reconstruction and bone regeneration technology licensed from the Universities of Michigan and Wisconsin. This innovative technology is applicable in various medical fields, including craniomaxillofacial surgery, orthopedic surgery, spine fusion surgery, and the delivery of bone growth factors. The company's devices utilize a biodegradable polyester polymer to facilitate spinal implants and repair damaged bones, enhancing surgical outcomes for conditions such as fractured orbital sockets and facial deformities. Tissue Regeneration Systems has successfully completed bench and animal testing and has filed initial regulatory submissions to the FDA, with expectations to commercialize its products in the United States and begin generating revenue in the coming years.

UpTo, Inc. is a company that specializes in developing a social calendar application for smartphones. Founded in 2011 and based in Detroit, Michigan, UpTo provides a platform that allows users to publish and manage their organization's calendar while privately connecting with friends, family, and colleagues to share events selectively. The application offers a streamlined view of important upcoming events, eliminating clutter and focusing on what matters most. Users can easily add events, syncing seamlessly across both mobile and web platforms, and can integrate with existing calendars such as Google Calendar and Outlook. The service is designed to cater to both individuals and organizations, enhancing the way they manage and share their schedules.

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

Tissue Regeneration Systems Inc. is a start-up medical device company based in Plymouth, Michigan, with an additional office in Kirkland, Washington, and a research facility in Ann Arbor, Michigan. Founded in 2005, the company specializes in a skeletal reconstruction and bone regeneration technology licensed from the Universities of Michigan and Wisconsin. This innovative technology is applicable in various medical fields, including craniomaxillofacial surgery, orthopedic surgery, spine fusion surgery, and the delivery of bone growth factors. The company's devices utilize a biodegradable polyester polymer to facilitate spinal implants and repair damaged bones, enhancing surgical outcomes for conditions such as fractured orbital sockets and facial deformities. Tissue Regeneration Systems has successfully completed bench and animal testing and has filed initial regulatory submissions to the FDA, with expectations to commercialize its products in the United States and begin generating revenue in the coming years.